Loading...
Loading...
NEW YORK, NY · CIK 0001263508
Portfolio Value
$12.33B
Positions
122
New
10
Increased
24
Decreased
11
Sold Out
10
BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $12.33B across 122 positions in their Q3 2017 SEC 13F filing (period ending 2017-09-30). The top 10 positions account for 85.9% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | INCYIncyte Corporation | $4.00B | 32.41% | +0.3% |
| 2 | SGENEURSeattle Genetics, Inc. | $2.49B | 20.18% | - |
| 3 | ALXNAlexion Pharmaceuticals, Inc. | $1.20B | 9.73% | - |
| 4 | ACADACADIA Pharmaceuticals Inc. | $972.63M | 7.89% | - |
| 5 | BMRNBioMarin Pharmaceutical Inc. | $549.64M | 4.46% | - |
| 6 | GHDXGenomic Health, Inc. | $442.21M | 3.59% | +0.0% |
| 7 | ONCBeiGene, Ltd. | $403.33M | 3.27% | +6.1% |
| 8 | DBV Technologies S.A. | $233.83M | 1.90% | - |
| 9 | Aquinox Pharmaceuticals, Inc. | $155.16M | 1.26% | - |
| 10 | AAAPGBPAdvanced Accelerator Applications S.A. | $151.69M | 1.23% | +1.0% |
| Stock | Value | Shares |
|---|---|---|
| BMRN 0.599 08/01/24BioMarin Pharmaceutical Inc. | $15.19M | 15,000,000 |
| Acorda Therapeutics, Inc. | $12.29M | 519,500 |
| GWPHGW Pharmaceuticals plc | $7.61M | 75,000 |
| VNDAVanda Pharmaceuticals Inc. | $7.59M | 423,884 |
| TTPHEURTetraphase Pharmaceuticals, Inc. | $6.39M | 935,000 |
| VYGRVoyager Therapeutics, Inc. | $4.88M | 237,014 |
| Clementia Pharmaceuticals Inc. | $4.22M | 250,000 |
| KRYSKrystal Biotech, Inc. | $1.99M | 200,000 |
| Molecular Templates, Inc. | $505.00K | 72,412 |
| TTOOT2 Biosystems, Inc. | $420.00K | 100,000 |
Get alerts when BAKER BROS. ADVISORS LP files new 13F holdings.